← Back to Search

Sensory Feedback Intervention for Speech Motor Learning

N/A
Recruiting
Led By David Ostry
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
no known physical or neurological abnormalities
Be between 18 and 65 years old
Must not have
surgical clips or values on the heart
currently taking antianxiety drugs
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours after learning (re-test lasts 30 minutes)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether or not the part of the brain that controls senses also affects the consolidation of speech motor memory.

Who is the study for?
This trial is for right-handed adults with no known physical or neurological abnormalities. It's not suitable for those with epilepsy, a family history of it, on antidepressants/antipsychotics/antianxiety drugs, with heart devices/metal in the body, who are pregnant, or have had concussions.
What is being tested?
The study tests if brain sensory areas help solidify speech motor memory. Participants undergo transcranial magnetic stimulation (cTBS) to suppress somatosensory and auditory cortex activity after speech adaptation exercises to see if this affects learning retention.
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, headache, lightheadedness or dizziness during cTBS application. There might also be temporary changes in hearing or speech perception.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any known physical or neurological abnormalities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have surgical clips or valves in my heart.
Select...
I am currently on medication for anxiety.
Select...
I am currently on antidepressants.
Select...
I am currently on antipsychotic medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours after learning (re-test lasts 30 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours after learning (re-test lasts 30 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Motor Learning
Retention of Learning

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Adaptation to Altered Sensory Feedback + cTBS to S1Experimental Treatment2 Interventions
Adaptation to Altered Sensory Feedback + cTBS to S1
Group II: Adaptation to Altered Sensory Feedback + cTBS to M1Experimental Treatment2 Interventions
Adaptation to Altered Sensory Feedback + cTBS to M1
Group III: Adaptation to Altered Sensory Feedback + cTBS to A1Experimental Treatment2 Interventions
Adaptation to Altered Sensory Feedback + cTBS to A1
Group IV: Adaptation to Altered Sensory Feedback + Sham cTBSExperimental Treatment2 Interventions
Adaptation to Altered Sensory Feedback + Sham cTBS

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,930 Previous Clinical Trials
3,033,314 Total Patients Enrolled
McGill UniversityOTHER
414 Previous Clinical Trials
1,015,281 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,898 Total Patients Enrolled
David OstryPrincipal InvestigatorHaskins Laboratories
6 Previous Clinical Trials
940 Total Patients Enrolled

Media Library

Adaptation Clinical Trial Eligibility Overview. Trial Name: NCT04497428 — N/A
Lung Consolidation Research Study Groups: Adaptation to Altered Sensory Feedback + cTBS to S1, Adaptation to Altered Sensory Feedback + cTBS to A1, Adaptation to Altered Sensory Feedback + cTBS to M1, Adaptation to Altered Sensory Feedback + Sham cTBS
Lung Consolidation Clinical Trial 2023: Adaptation Highlights & Side Effects. Trial Name: NCT04497428 — N/A
Adaptation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04497428 — N/A
~16 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top